Efficient fluorescence-based imaging methods for quantitating infectivity and oncolytic efficacy of Newcastle disease virus

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 390-397

  Sen Sharma, K ^a   Moorkanat, G ^b   Qiao, D ^b   Bell, A E ^a   Samal, S K ^c   Elankumaran, S ^b  

^a Virginia Polytechnic Institute and State University   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

GFP; Imaging alternative; Oncolytic efficacy; Plaque assay; Viral infectivity quantitation

Indexed keywords

ONCOLYTIC PARAMYXOVIRUS;

ARTICLE; CELL KILLING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE QUALITY; IMAGING SYSTEM; INTERMETHOD COMPARISON; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; TUMOR CELL DESTRUCTION; VIRUS CULTURE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS TITRATION;

CELL LINE; CELL LINE, TUMOR; FLUORESCENCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIRUSES; PLAQUE ASSAY; STATISTICS AS TOPIC; VIRAL LOAD;

NEWCASTLE DISEASE VIRUS;

EID: 73049109801     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.10.030     Document Type: Article

References (17)

1. Cruz D.J.M., and Shin H. Application of a focus formation assay for detection and titration of porcine epidemic diarrhea virus. J. Virol. Methods 145 (2007) 56-61
2. Elankumaran S., Rockemann D., and Samal S.K. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J. Virol. 80 (2006) 7522-7534
3. Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., and Abraham G.N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53 (1993) 5274-5283
4. Garber K. China approves world's first oncolytic virus therapy for cancer treatment. J. Natl. Cancer Inst. 98 (2006) 298-300
5. Janakiraman V., Forrest W.F., Chow B., and Seshagiri S. A rapid method for estimation of baculovirus titer based on viable cell size. J. Virol. Methods 132 (2006) 48-58
6. Johnson M.C., Damon I.K., and Karem K.L. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein. J. Virol. Methods 150 (2008) 14-20
7. Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Straus S.E. Field's Virology. fifth edition (2007), Lippincott Williams & Wilkins, Baltimore
8. Lonsdale R., Pau M.G., Oerlemans M., Ophorst C., Vooys A., Havenga M., Goudsmit J., UytdeHaag F., and Marzio G. A rapid method for immunotitration of influenza viruses using flow cytometry. J. Virol. Methods 110 (2003) 67-71
9. Payne A.F., Binduga-Gajewska I., Kauffman E.B., and Kramer L.D. Quantitation of flaviviruses by fluorescent focus assay. J. Virol. Methods 134 (2006) 183-189
10. Purcell M.K., Hart S.A., Kurath G., and Winton J.R. Strand-specific, real-time RT-PCR assays for quantification of genomic and positive-sense RNAs of the fish rhabdovirus, infectious hematopoietic necrosis virus. J. Virol. Methods 132 (2006) 18-24
11. Schalk J.A.C., van den Elzen C., Ovelgönne H., Baas C., and Jongen P.M.J.M. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR. J. Virol. Methods 117 (2004) 179-187
12. Steel J.C., Morrison B.J., Mannan P., Abu-Asab M.S., Wildner O., Miles B.K., Yim K.C., Ramanan V., Prince G.A., and Morris J.C. Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus. Virology 369 (2007) 131-142
13. Ueno T., Eizuru Y., Katano H., Kurata T., Sata T., Irie S., and Ogawa-Gotol K. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that use a green fluorescent protein-PML-expressing cell line. Antimicrob. Agents Chemother. 50 (2006) 2806-2813
14. Vigil A., Park M., Martinez O., Chua M.A., Xiao S., Cros J.F., Martínez-Sobrido L., Woo S.L.C., and García-Sastre A. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res. 67 (2007) 8285-8292
15. Wang Z., Mo C., Kemble G., and Duke G. Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein. J. Virol. Methods 120 (2004) 207-215
16. Wong R.J., Kim S., Joe J.K., Shah J.P., Johnson P.A., and Fong Y. Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. JACS 193 (2001) 12-21
17. Zamarin D., Vigil A., Kelly K., García-Sastre A., and Fong Y. Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther. 16 (2009) 796-804